Latest News about COVID/19 vaccine
Recent news which mentions COVID/19 vaccine
   President Biden Gets Second COVID-19 Booster, Pushes Additional Funding For Future Preparedness
   
  
  
  March 31, 2022
  From Benzinga
 
   Omicron More Severe For Unvaccinated Children Than Other Strains, Hong Kong Study Finds: Bloomberg
   
  
  
  March 31, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
   
  
  
  March 30, 2022
  From Benzinga
 
   FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People
   
  
  
  March 29, 2022
  From Benzinga
 
   Pfizer, Moderna and J&J Face Shareholder Pressure To Make COVID-19 Shots More Available To Poorer Countries: WSJ
   
  
  
  March 28, 2022
  From Benzinga
 From Benzinga
 
   Biden Administration Contemplating Second COVID-19 Booster Shot Recommendation Within Weeks: Politico
   
  
  
  March 23, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Novavax's COVID-19 Vaccine Scores Green Light In India with First Approval For Adolescents
   
  March 23, 2022
  Tickers 
   NVAX
  
  
  From Benzinga
 From Benzinga
 
   Sorrento's Chimeric mRNA COVID-19 Vaccine Candidate Shows Preclinical Action Against Omicron Variants
   
  March 21, 2022
  Tickers 
   SRNE
  
  
  From Benzinga
 
   Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters
   
  
  
  March 18, 2022
  From Benzinga
 
   Like Pfizer, Moderna Seeks FDA Approval For Fourth COVID-19 Shot Or Second Booster Dose
   
  
  
  March 18, 2022
  From Benzinga
 From Benzinga
 
   Alnylam Hits Pfizer, Moderna With Patent Infringement Suits
   
  
  
  March 17, 2022
  From Benzinga
 
   Dynavax Adjuvanted Clover Bio's COVID-19 Vaccine Booster Shows Durable Protection Against Omicron
   
  
  
  March 17, 2022
  From Benzinga
 
   WHO Foundation Warns Global Economy To Lose "Trillions Of Dollars" On COVID-19 Vaccine Inequality: CNBC
   
  
  
  March 16, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Pfizer-BioNTech's COVID-19 Shot Moderately Effective Against Omicron In Kids Aged 5 to 15, CDC Study Shows
   
  
  
  March 14, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

